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We found distinct patterns of intercellular adhesion 
molecule-l (ICAM-l) expression in three diseases 
characterized by interface dermatitis with mononu­
clear infiltrates and keratinocyte cytotoxicity: lichen 
planus (LP), subacute cutaneous lupus erythematosus 
(SCLE), and erythema multiforme (EM). In LP, basal 
keratinocytes show strong ICAM-l expression associ­
ated with a dermal infiltrate, but ICAM-l expression 
in the rest of the epidermis is minimal. In SCLE, there 
is diffuse epidermal ICAM-l expression, sometimes 
with accentuation on the cell surface of basal cells. In 
EM, there is strong basal cell expression of ICAM-l 
with evident cell surface accentuation, and also 
pockets of suprabasal expression with cell surface 
accentuation. These patterns are associated with dif­
ferent factors that trigger cytokine release in differ­
ent locations. 
Both tumor necrosis factor-a (TNF-a) and inter­
feron-l' (IFN-1') produce greater relative ICAM-l 
expression in basal keratinocytes than in more differ­
entiated keratinocytes. In LP, the pure basal kerati­
nocyte expression ofICAM-l appears to be caused by 
cytokines, predominantly IFN-l', released by dermal 
lymphocytes. The pattern of ICAM-l in SCLE corre­
sponds to the pattern induced by ultraviolet radiation 
(UVR): diffuse epidermal ICAM-l expression, some-
I ntercellular adhesion molecule-l (ICAM-l) (CD54) is a member of the immunoglobulin supergene family and is a single-chain glycoprotein weighing between 76 and 114 kD [1,2]. ICAM-l is the major ligand for leukocyte function associated antigen-l, an adhesion molecule found on all 
leukocytes [3]. Both molecules are inducible by a number of 
cytokines and the affinity of leukocyte function associated antigen-l 
for ICAM-l can be increased by triggering numerous leukocyte 
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times with basal accentuation. Some individuals are 
"responders" to TNF-a or UVR, showing high levels 
ofICAM-l expression following UVR or TNF-a stim­
ulation in vitro or UVR stimulation in vivo. We pro­
pose that the pattern ofICAM-l induction in SCLE is 
dependent on UVR-induced TNF-a release. 
EM is associated with apparent latent Herpes sim­
plex virus, and Herpes simplex virus (HSV)-infected 
keratinocytes show enhanced ICAM-l expression. 
We propose that in EM suprabasal ICAM-l expression 
may be induced directly by HSV infection or indi­
rectly through TNF-a release induced by HSV reac­
tivation. 
Induction ofICAM-l within the epidermis is strat­
ified and individually variable. Basal keratinocytes 
show maximal induction of ICAM-l expression due 
to innate sensitivity to TNF and IFN-l' stimulation, 
and to location adjacent to dermal sources of cyto­
kines. Suprabasal ICAM-l can be induced by UVR 
and epidermal TNF-a release, and by factors such as 
viral infection. Different triggers of cytokine release 
and adhesion molecule induction may influence the 
different patterns of inflammation seen in diverse 
inflammatory skin diseases. Key words: TNF/IL-1Iinter­
feronllupus erythematosusllichen planus/erythema multi­
forme. ] Invest Dermatol 105:71S-79S, 1995 
cell-surface receptors [4 , 5] . This ligand/receptor pair is essential in 
many contact-dependent interactions between leukocytes and tis­
sue cells, in specific antigen recognition by B and T lymphocytes, in 
superantigen stimulation ofT lymphocytes, in leukocyte migration 
into tissue, and in leukocyte-mediated cytotoxicity [6-8]. It has 
been proposed that this adhesion pair is crucial in directing 
activated leukocytes into tissue and in initiating and strengthening 
leukocyte attachment to parenchymal targets, facilitating specific 
recognition and subsequent cytotoxicity [9,10]. 
In contrast to endothelial cells, and other parenchymal cells, 
keratinocytes have very low constitutive expression of cell-surface 
ICAM-l [11]. The lack of expression of ICAM-l renders the 
resting epidermis resistant to interaction with leukocytes. Induction 
ofICAM-l expression in the epidermis is proposed as an important 
factor in the induction of leukocyte-dependent damage to kerati-
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Figure 1. ICAM-1 staining in skin biopsies from LP, EM. and SCLE: immunohistochemical staining for ICAM-1 in biopsies from control 
normal skin (A). SCLE (B,C). EM (D), and LP (E,P). Sections were photographed at both medium (100X) and high power (400X). 
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nocytes and melanocytes, especially immunologic cytotoxicity 
[9,12,13]. 
Induction of expression ofICAM-l on epidermal keratinocytes is 
found in many diverse inflammatory skin conditions including 
contact dermatitis, lichen planus (LP) , pemphigus, fixed drug 
reactions, erythema multiforme (EM), and subacute cutaneous 
lupus erythematosus (SCLE) [14-16]. It has been proposed by 
Nickolo1f et al that induction ofICAM-l may be a "final common 
pathway" in the pathophysiology of these inflammatory skin dis.,­
eases [17]. 
We propose that the pattern of expression and the inducers of 
ICAM-l expression may vary in di1ferent skin diseases. We have 
identified three di1ferent patterns of ICAM-l expression in three 
diseases characterized by an interface dermatitis and keratinocyte 
cytotoxicity: LP, EM, and SCLE. These patterns can be explained 
by the stratified epidermal environment of induced ICAM-1 ex­
pression and by di1ferent triggers of ICAM-l in the three diseases. 
MATERIALS AND METHODS 
Immunopathology Studies We obtained skin biopsies from four 
groups of six patients: nonnal controls (cosmetic plastic surgery), EM, LP, 
and SCLE. Punch biopsies were taken from lesional skin and also non­
lesional skin of SCLE patients . 
The tissue was snap-frozen and sectioned into 4-micron sections on a 
tissue-tek cryostat. The sections were air-dried and fixed in 100% acetone. 
These sections were washed three times in phosphate-bulfered saline (PBS) 
and incubated in blocking sera for 20 min . The tissue was incubated in an 
IgG1 monoclonal anti-human ICAM-l RRl/1 (graciously provided by 
Robert Rothlein, Boehringer-Ingelheim) for 30 min and washed in PBS. 
The sections were then stained ntilizing the avidin-biotin peroxidase 
complex immunoperoxidase method (ABC Vectastain, Vector Lab). The 
specificity of this antibody for rCAM-1 has been previously reported [2], 
and the usefulness in studying skin disease has been established [14]. 
Negative control sections used an IgGl isotype-matched control mouse 
anti-human IgA that does not bind normal keratinocytes. 
Cell Cultures Human keratinocytes were cultured from neonatal fore­
skins as previously described [13] in keratinocyte growth media (KGM, 
Clonetics, San Diego, CA), and studied at the time of third passage. 
Keratinocyte strains were usually obtained from a single foreskin source. 
Adult-derived keratinocytes were obtained from suction blister as described 
[18]. 
In some priming experiments, transfonned epithelial or keratinocyte cell 
lines were studied . KB and A431 cell lines were obtained from the American 
Type Culture Collection, and HaCaT cells were generously provided by 
Norbert Fusenig of the Deutsches Krebsforschungszentrum in Heidelberg, 
Gennany. 
ICAM-l Expression Cells were cultured in six-well plates for 2 d 
followed by stimulation by 30 ng TNF-a/rul (Genzyme, 2 X 108 ng/mg, 
Cambridge , MA) or by 20 U IFN-')I (Genzyme, 2.5 X 107 U/mg). 
Cell-surface ICAM-l expression was measured by flow cytometry at the 
time of peak expression, which was 1 d following stimulation by IFN-')I and 
3 d following stimulation by TNF-a [13]. 
Phototesting The effect of ultraviolet (UV) light on human skin and 
ICAM-l induction was carried out utilizing a Dennalight 2001 Sol 3 Solar 
Simulator (Dennalight Systems, Studio City, CA). This light source emits 
both UVB and UV A, but UVC and the lower range of the UVB spectrum 
are attenuated by filters; the emission spectrum of the source has been 
previously published [19]. The flux in the UVB spectrum was monitored 
with an International Light IL17001760D1791 radiometer (International 
Light, Newburyport, MA), and the time of exposure was adjusted to deliver 
50 or 100 mJlcm2 of UVB. Five volunteers were exposed on the volar 
surface of the forearm to 50 m]lcm2 or to 100 m]lcm2 at the same site for 
three subsequent days or to 100 mJlcm2 on a single day. All five subjects 
were skin type II; the doses were roughly 1 and 2 times the minimal 
erythema dose (MED), respectively. Skin biopsies were taken from the 
volar forearm 24 h after the last UVR exposure and processed for ICAM-l 
immunoperoxidase staining. 
Measuring ICAM-l Expression in Herpes Simplex Virus (HSV)­
Infected Keratinocyte Cultures We utilized the technique previously 
described by Brice et al [20] for measuring the effects of HSV infection of 
keratinocyte cultures on rCAM-l expression. Human keratinocyte cultures 
were incubated with reagent grade acyclovir (Burroughs Wellcome, Gre­
enville, NC) at 200 /LM to inhibit the pace of productive HSV infection. 
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Table I. ICAM-1 Patterns in Three Diseases with 
Keratinocyte Cytotoxicity 
Disease Epidermal rCAM-I" Other Features 
SCLE 
EM 
LP 
Normal Skin 
Dilfuse epidennal 
ICAM-l (1-2+) 
Sometimes basal 
layer accentuation 
Dense basal layer 
ICAM-l (3-4+) 
Pockets of positive 
suprabasal staining 
(3-4+) 
Intense basal layer 
ICAM-l (3- 4+) 
Negative for epidermal 
ICAM-l 
Faint leukocyte staining in 
the dermis 
Intense leukocyte staining 
in the dermis 
Intense leukocyte 
ICAM-l in the dermis 
Mild endothelial cell 
rCAM-l 
a Staining intensity: 1 +, taint staining, patchy; 2 +, more positive, more unifo.rril; 
3+. more positive, uniform, cell surface; 4+, very positive, unifo� cell surface. 
The cultures were infected at a multiplicity of infection of 1.0. At different 
times following infection, the cultures were harvested and ICAM-l expres­
sion was measured quantitatively by fluorescence-activated cell sorter 
(FACS) analysis. These experiments were repeated four times. In addition, 
at 24 h, ICAM-l expression induced by HSV infection was compared to 
that induced by IFN-')I versus medium control. 
Priming of Cytokine Responses To determine whether pre-treatment 
("priming") with small amounts of TNF-a would enhance the subsequent 
response to optimal doses of cytokine, keratinocytes were incubated with a 
single suboptimal dose ofTNF-a (the "priming" dose) for 3 d. This TNF-a 
was then washed away and 30 ng TNF-alml was added. and the cells 
incubated for an additional 3 d before assay for ICAM-l expression. 
Cytokines Human recombinant TNF-a and IFN-')I from Genzyme were 
used throughout. 
RESULTS 
Three Distinct Patterns ofICAM-l Expression In the three 
different diseases studied, the expression ofICAM-1 in the epider­
mis showed three di1ferent patterns as summarized in Table I and 
illustrated in Fig 1. In normal skin, ICAM-l expression is unde­
tectable in the epidermis, and limited in dermal vessels (Fig 1A). In 
SCLE, ICAM-l expression was di1fuse throughout the epidermis 
(Figs 1B,C), occasionally with accentuation in the basal layer (Fig 
1 C). In SCLE the staining was found to be either cytoplasmic (Fig 
1B) or cell surface (Fig lC). Non-Iesional skin in SCLE did not 
demonstrate increased ICAM-1 expression either in the epidermis 
or dermis over the normal controls. EM typically demonstrated 
strong diffuse keratinocyte surface staining for ICAM-l in most 
areas with accentuation at the basal cell layer. The ICAM-l staining 
was not homogeneous with a few areas demonstrating little or no 
staining of the epidermis as illustrated in the central area of the 
epidermis pictured in Fig lD. In the papillary dermis there was also 
strong ICAM-l staining of the vessels (endothelial cells) and of the 
mononuclear cell infiltrate (Fig 1D). In LP keratinocyte cell­
surface and cytoplasmic expression of ICAM were observed in a 
patchy distribution (+ 3-4) concentrated in the basal cell areas 
adjacent to the dense infiltrate of ICAM( +) lymphocytes in the 
upper and papillary dermis. There was significant strong increase in 
ICAM-l staining in the endothelial cells in these cases, especially 
around the papillary vessels; however, the endothelium staining for 
ICAM was variable (Fig 1E,F). 
Preferential ICAM-1 Expression in Basal Keratinocytes 
Keratinocyte di1ferentiation is a potent influence on induction of 
ICAM-1. As illustrated in Fig lA, keratinocytes grown in low­
calcium medium had the greatest induction ofICAM-l expression 
following stimulation with either TNF-a or IFN-I'. Cells grown in 
low-calcium medium have the least di1ferentiated phenotype. The 
FACS profiles of cells grown in medium containing di1ferent 
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calcium concentrations and then stimulated with cytokines are 
shown in Fig 2B,C, allowing examination ofICAM-l distribution 
within the entire cell population. Neither the baseline ICAM-l 
expression nor the pattern of ICAM-l expression in cytokine 
stimulated cells is different in cells with calcium-altered differenti­
ation phenotype. However, the absolute level of ICAM-l (log 
mean) is greater for both TNF-a (Fig 2B) and IFN-y (Fig 2q 
stimulation. The variability of response as measured by coefficient 
of variation and standard deviation is no different in the high- and 
low-calcium conditions. 
Induction of ICAM-l Expression in Keratinocytes by 
TNF-a and UVR We have previously shown that ICAM-l 
induction by cytokines may be quite variable in different individu­
als, and that some individuals may be "responders" and others 
"non-responders" [21]. In those studies, the responses to TNF-a 
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Figure 2. Effect of keratinocyte differentiation on induction of 
ICAM-l expression. a) ICAM-l expression in keratinocytes grown in 
high- (1.0 mM). mediwn- (0.15 mM). or low- (0.03 mM) calcium 
concentration. The bars and brackets represent the mean :i: SEM of six 
diJferent experiments. Cells were stimulated with optimal TNF-a concen­
tration for 3 d or optimal IFN-1' concentration for 1 d. Induced ICAM-l 
expression was greater in the less diJferentiated keratinocytes for both IFN-1' 
(p = 0.015) and TNF-a (p = 0.050). b) FACS profiles for keratinocyte 
cultures grown in three diJferent calcium concentrations. IgA indicates the 
anti-IgA isotype-matched negative control, whereas the other curves 
represent anti-ICAM-1 staining with interferon (IFN 20 U) and without 
interferon (No IFN). Log mean indicates a summation of the intensity of 
staining; Co.Var. and St. Dev. indicate the variability of staining. c) Similar 
experiment showing ICAM-l cell-surface expression after stimulation with 
TNF (TNF 30 ng in duplicate) or without TNF (No TNF). 
and UVR were closely correlated in individual keratinocyte cul­
tures. 
We':selected five subjects whose cultured keratinocytes were 
either responders or non-responders in vitro to TNF-a as judged by 
level of induced ICAM-l expression. In Table n the expression of 
ICAM-l of cultured keratinocytes from responders and non­
responders to TNF-a is compared to the induction in vivo of 
ICAM-1 expression by UVR in the same adult subjects. There is a 
positive correlation between the increase in ICAM-1 expression in 
response to TNF-a and the in vivo response to UVR as demon­
strated by ICAM-l staining in the epidermis. The non-responders 
had minimal ICAM-l expression on their cultured keratinocytes 
when exposed to TNF-a and no ICAM-l expression in their 
epidermis on exposure to UVR. This comparison clearly demon­
strates the differences between non-responders and responders: 
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Table II. ICAM-l Induction in Keratinocytes and 
Epidermis by UVR and TNF-a 
UV Irradiation In Vivo 
TNF-a 
In Vitro 100 50 100 mJlcm2 
Subjects" ICAM-l 0 (1 d) (3 d) (3 d) 
Nonresponders 
MM 22b OC 0 0 0 
SS 40 0 0 0 0 
Responders 
JB 67 0 3+ 2+ 2+ 
SB 107 1+ 2+ 3+ .3+ 
DN 64 0 1+ 2+ 2+ 
• All five subjects were skin type II, with similar minimal erythemia doses. In all 50 
mJ/cm2 and 100 mJ/cm2 represented approximately 1 and 2 minimal erythemia doses, 
respectively. 
b Tn vitro increase in ICAM-l (log mean fluorescence) afier TNF-a stimulation of 
keratinocyres for three days. 
'Degree of diffuse epidermal staining for ICAM-1 of biopsies ofUV-irradiated skin. 
responders did up-regulate ICAM-l expression on keratinocytes in 
vitro after TNF-a stimulation and in vivo after UVR exposure. All 
five subjects were Caucasians with type II and similar minimal 
erythema doses on phototesting . 
The immunohistochemical staining in vivo and the FACS profiles 
are illustrated in Fig 3 for one nonresponder (MM) and three 
nonresponders (DN. ]B. and SB). In all subjects. control non­
irradiated skin had negative epidermal ICAM-l staining. Multiple 
sequential daily irradiation produced more epidermal damage than 
a single daily dose. but did not necessarily produce greater ICAM-l 
expression (Table 11). 
Induction of Expression ICAM-l by HSV As shown in 
Table III, there is a small increase in ICAM-l expression in 
keratinocytes infected with HSV. The fold increase in cell-surface 
ICAM-l was 1.65 for HSV infection and 9 when the HSV -infected 
cells were exposed to IFN-y. Similar levels of ICAM-l induction 
were seen out to 40 h (data not shown). 
Priming with TNF Significandy Enhances Subsequent Re­
sponse to TNF The expression of ICAM-l on human kerati­
nocytes in culture was evaluated after priming and challenge doses 
of TNF-a. Priming with suboptimal doses of TNF-a produced 
small increases in ICAM-l expression when no TNF-a was used as 
challenge (Fig 4). However. significant enhancement of ICAM-l 
expression was seen with priming with 0.03. 0.3. or 3.0 ng/ml of 
TNF-a when the cells were subsequently challenged with 30 ng/ml 
ofTNF. 
Priming with TNF-a was also tested in cells challenged with 
exposure to UVR. In this experiment. there were small increases in 
ICAM-1 expression (Fig 5) when irradiated cells were primed with 
suboptimal TNF-a (0.3 and 3.0 ng/ml). 
Lack of Priming with interleukin 1 (IL-l) in Keratinocytes 
and Epithelial Cell Strains A direct comparison of IL-1 
responses of normal human keratinocytes to the responses of three 
transformed keratinocyte or epithelial cell lines is shown in Table 
IV. As previously described.; KB cells have greater baseline 
ICAM-l expression and show a substantial induction of ICAM-1 
expression by IL-l (1.0 ng/ml). This level of IL-1 (1.0 ng/ml) will 
induce significant responses such as IL-8 production in keratino­
cytes. but not increased ICAM-1 expression (data not shown). 
However, pretreatment of the four cell lines or strains with 
suboptimal IL-1 fails to induce priming of any of the cell lines. in 
distinction to the priming seen with TNF (Figs 4 and 5). In 
* Middleton MH. Arend wp. Norris DA: High intracellular interleu­
kin-I receptor antagonist (icIL-1ra) levels are correlated with low expres­
sion of intercellular adhesion molecule-l (ICAM-1) in keratinocytes and 
fibroblasts (abstr). ] Invest Dermotol 102:524. 1994. 
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addition. IL-1 at 0.1 ng/ml does not prime for subsequent responses 
to TNF-a or UVR (data not shown). 
DISCUSSION 
The diversity of ICAM-1 staining patterns in various cutaneous 
diseases is relatively remarkable considering the fairly limited 
repertoire of cytokines that are known to up-regulate the expres­
sion of ICAM on keratinocytes. We found that the pattern of 
ICAM-1 expression in the epidermis was quite different in LP, EM. 
and SCLE. even though all are associated with keratinocyte cyto­
toxicity and a mononuclear infiltrate. To further describe the 
different patterns of ICAM-l in the suprabasallayer in SCLE and 
EM. we further investigated the roles of the apparent trigger factors 
UVR and HSV infection on the induction oflCAM-1 expression in 
human keratinocytes . 
ICAM-l expression is induced in many cell types by the cyto­
kines TNF-a and TNF-f3. IL-l. and IFN-y. In keratinocytes. 
ICAM-l expression is constitutively suppressed by the upstream 
promoter region [22]. and can be induced by TNF-a and TNF-f3. 
IFNy. and UVR, but not by IL-1 [11.13.21.23]. Injection ofIL-l 
intradermally induces ICAM-1 expression in vivo, presumably by 
release ofTNF-a [24]. Our own studies indicate that high levels of 
intracellular IL-lra in human keratinocytes may act to down­
regulate baseline ICAM-1 expression and actually block subsequent 
IL-1 induction ofICAM-l expression.; 
In LP. the basal cells of the epidermis. especially those adjacent to 
the lymphocytic infiltrate in the papillary dermis. are heavily 
adorned with ICAM-1 [14]. The cytokines IFN-y and TNF 
produced by the dermal mononuclear infiltrate in lichenoid derma­
titis have been implicated in previous studies as inducers of 
epidermal damage [25.26]. The basal keratinocytes are particularly 
susceptible to ICAM-l induction by these cytokines . as demon­
strated in these and previous studies [27]. Studies of cloned T cells 
also have shown that T cells can secrete lymphokines in a focused 
directional fashion [28]. This would allow dermal lymphocytes in 
LP to "target" basal layer keratinocytes by secreting lymphokines 
in a directed fashion. This may explain the highly localized and 
intense ICAM-l staining we found in the basal keratinocytes in LP. 
The failure to block this reaction with anti-TNF raises doubt about 
the role of TNF-a in lichenoid reactions [25]. The lack of 
suprabasal ICAM-1 staining in LP is most consistent with leuko­
cyte-derived cytokines. but not epidermal TNF as inducers of 
ICAM-1 expression. 
EM exhibits a totally different pattern ofICAM-1 expression than 
LP. involving the entire epidermis as demonstrated in Fig ID. It 
frequendy shows foci of ICAM-l expressed on the surface of 
keratinocytes in the mid and upper epidermis. Brice and colleagures 
demonstrated HSV protein [29] and genome [30] in the epidermis 
in EM lesions. but not in areas of repeated EM between episodes. 
The diffuse binding of the probe for HSV in those studies is similar 
to the diffuse ICAM-l staining found in our EM biopsies. In our ill 
vitro studies ofHSV effect on ICAM-l expression. we found that 
HSV infection could induce modest expression of ICAM-1 on 
keratinocytes (Table 111). In addition. several studies have dem­
onstrated that HSV-infected keratinocytes can produce interferons 
[31.32] and also TNF-a [33]. which might induce keratinocytes to 
up-regulate ICAM-1 on their cell surfaces in an autocrine or 
paracrine fashion. Another cytokine present in keratinocytes in high 
quantity is IL-l [34-36]. It is reasonable to conclude that viral 
damage and subsequent degeneration of keratinocytes may release 
IL-1 in quantities great enough to induce increased ICAM-1 
expression indirecdy through increased inflammation. However. as 
noted earlier. IL-1ra is also present within keratinocytes [34.37] and 
may act to down-regulate the effect ofIL-l locally. 
In biopsies of lesional skin from SCLE. keratinocytes showed 
either a diffuse cell membrane ICAM-1 staining or a diffuse 
cytoplasmic staining (Fig IB,C). These patterns were similar to the 
patterns seen in UVR-induced ICAM-l in patients who were 
determined to be TNF-a responders by ill vitro testing of their 
keratinocytes (Fig 2. DN.]B. and SB). The strong coincidence of 
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Figure 3. Response to TNF in vitro correlates with response to UVR in vivo. Compariso n ofICAM-l induction in vitro by TNF-� with ICAM-l 
induction i,t vivo with UVR in four of the five subjects described in Table U. The ICAM-l induction in vitro was measured by FACS analysis. In this analysis, 
an isotype-matched negative control (JgA = anti IgA) antibody binding is compared with baseline cultures (no cytokine) and duplicate cultures stimulated 
with cytokine (TNF-�). These data are shown in the left column as FACS tracings and ICAM-l expression (log mean). In the right column the 
immunohistochemical staining for ICAM-l is presented for each subject shown in the left column. In vitro responders were defined as those who increased 
ICAM-l expression greater than a 50 increase in log mean after TNF stimulation (see Table U). Responders in vitro to TNF-� showed increased epidermal 
ICAM-l in vivo following UVR. 
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Table m. Herpes Simplex Infection Stimulates Low­
Level ICAM-l Expression 
Experimental Percent Log Mean Fold 
Condition Positive Fluorescence Increase 
Negative Control 0 lS.7 
Anti-lgA 
HSV infected 
ICAM-l control 4.9 22.7 1.0 
Anti-ICAM-l 
HSV-
ICAM-l: HSV induced 21.2 37.5 �.65 
Anti-ICAM-l 
HSV+ 
Positive control 7S.6 202 9.0 
ICAM-l: IFN-y induced 
Anti-ICAM-l 
HSV+ 
IFN-y+ 
the ICAM-1 patterns in SCLE and in the UVR-irradiated skin of 
responders supports the hypothesis that UVR induces ICAM-1 
expression in highly photosensitive SCLE patients . It also supports 
the hypothesis that UVR susceptibility, perhaps mediated through 
TNF-a release and response, is an important determinant of who 
will develop SCLE. We have previously shown that the UVR and 
TNF-a induction of ICAM-1 expression in keratinocytes are 
linked, and that susceptibility to UVB and TNF-a correlates in cell 
strains from di1ferent individuals [21]. We have also shown that 
UVR induces TNF-a release from keratinocytes, but in different 
levels from di1ferent individuals [21]. This work extends these 
observations to link ICAM-1 expression in SCLE lesions to TNF-a 
dependent induction by UVR. Priming ofkeratinocyte response by 
prior exposure to low levels of TNF-a or UVR may be one 
mechanism by which low-level repeated exposures to stimuli (such 
as UVR or latent HSV) may potentiate ICAM-1 induction within 
the epidermis to subsequent stimulus. Trefzer et al [38] have shown 
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Figure 4. Suboptimal TNF "primes" keratinocytes for subsequent 
response to TNF. The effect of priming of keratinocyte cultures with 
suboptimal levels of TNF-a on the subsequent response to TNF-a is 
illustrated. The ICAM-l expression of cultured human keratinocytes is 
expressed as delta log mean fluorescence (stimulated values minus negative 
control) . In this experiment, cells were prime d on day -3 with one offour 
doses ofTNF, an d then challenged on day 0 with 0 or 30 ng/ml TNF. On 
day 3, the ICAM-l expression was measured. Significant (p < 0.01) priming 
of response was seen with TNF primary dose of 0.03, 0.3, and 3.0 ng/m!. 
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Figure 5. Priming with TNF enhances response to UVR. The effect 
of priu1ing with suboptimal doses of TNF-a is shown on subsequent 
ICAM-l expression following exposure to UVR. Cells were primed on day 
-2 with three doses ofTNF-a and then challenged with UVR on day O. 
ICAM-l expression was measured by FACS on day +3. TNF at 0.3 and 3.0 
ng/ml enhanced subsequent response to UVR. 
that TNF-a and UVR both induce increases in TNFR mRNA, 
associated with enhanced TNF-a dependent responses. Krutmann 
and Grewe also propose that UVR can induce IL-1-mediated 
priming through upregulation ofIL-l type I receptors [39]. In our 
hands, lL-1 will not prime keratinocytes to subsequent increases in 
ICAM-1 expression in response to IL-1 [39]. 
We propose that the epidermis is a stratified environment with 
respect to ICAM-1 induction (Fig 6). The basal keratinocytes are 
exposed to synergistic stimulation by TNF plus IFN--y [17] andlor 
TNF and histamine [40], and are intrinsically the most responsive of 
the keratinocytes in induction ofICAM-1 expression. However, in 
some diseases , suprabasal ICAM-l expression is also induced by 
exogenous factors such as UVR. Release of TNF-a and lL-1 by 
UVR may induce ICAM-1 expression in the suprabasal epidermis, 
but the response appears to be complex and individually variable. 
Our work suggests that low-level TNF-a release (by UVR or HSV 
Table IV. IL-l PrUning ofKeratinocyte for Induction of 
ICAM-l Expression by IL-l 
ICAM-l Expression (log mean) 
IL-l 
Cell Strain No IL-l Stimulation 
or Line Stimulation Stimulationa After Priming" 
HI{ se 13 13 
HaCaT 6 6 5 
A431 4 20 12 
KB 23 72 59 
• (L-t stimulation (1.0 ng/mI) at day 0 followed by measurement of ICAM-I 
expression at day 1. This level of !L-l induces keratinocytes to produce IL-B (data not 
shown). 
b Priming with !L-l (0.1 ng) at day -1, followed by stimulation with !L-t (I ng) at 
day 0, and measurement of ICAM-t expression at day 1. Day 1 is the point of 
maximum stimulated ICAM-l expression. 
, Log mean ICAM-l by FACS analysis. The data in this table represent a single 
experiment performed on the same day comparing all four cell types. The lack of 
priming by !L-l has been verified in multiple experiments using priming for IL-l 
response and also priming by IL-l for TNF-a- and UVR-induced I CAM-l expression. 
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Figure 6. The epidermis is a stratified environment with respect to 
ICAM-l induction. The greatest level of ICAM-l induction is seen in 
basal keratinocytes stimulated with IFN-'Y or TNF-a. UVR induces TNF-a 
release in the suprabasal epidermis and also lL-l a and IL-lra release 
from damaged keratinocytes in the suprabasal epidermis. These cytokines 
might regulate suprabasal or basal ICAM-l expression directly or by 
priming the target cells for subsequent responses to cytokines. However, in 
human keratinocytes, iclL-lra appears to limit IL-l-induced ICAM-l 
expression. 
infection) may "prime" the epidermis to express significant 
ICAM-l with continued suboptimal exposure. 
rhe functional significance of clliferential expression of ICAM-1 
within the levels of the epidermis is not yet known. In the three 
diseases considered here, cytotoxic damage of basal cells is seen, but 
more extensive suprabasal epidermal cytotoxic damage can also be 
seen in EM and in SCLE. This suggests that ICAM-1-positive 
suprabasal keratinocytes are rendered susceptible to immunologic 
damage, perhaps through ICAM-1-mediated interaction of kerati­
nocytes with activated cytotoxic leukocytes. 
T1lis work was supporred by Grants R01 AR26427 atld T32 AR0741 1 .froln tile 
Natiollal Institutes of Hen/tit. 
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